These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8084529)

  • 41. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP
    Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
    Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurotensin activates GABAergic interneurons in the prefrontal cortex.
    Petrie KA; Schmidt D; Bubser M; Fadel J; Carraway RE; Deutch AY
    J Neurosci; 2005 Feb; 25(7):1629-36. PubMed ID: 15716398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
    Zhang Y; Zhu S; Yi L; Liu Y; Cui H
    Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692.
    Azzi M; Nicot A; Gully D; Kitabgi P; Bérod A; Rostène W
    Neurosci Lett; 1994 May; 172(1-2):97-100. PubMed ID: 8084546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.
    Rostene W; Azzi M; Boudin H; Lepee I; Souaze F; Mendez-Ubach M; Betancur C; Gully D
    Ann N Y Acad Sci; 1997 Apr; 814():125-41. PubMed ID: 9160965
    [No Abstract]   [Full Text] [Related]  

  • 47. Autoradiographic and electrophysiological evidence for the existence of neurotensin receptors on cultured astrocytes.
    Hösli E; Stauffer S; Hösli L
    Neuroscience; 1995 Jun; 66(3):627-33. PubMed ID: 7644026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists.
    Azzi M; Gully D; Heaulme M; Bérod A; Pélaprat D; Kitabgi P; Boigegrain R; Maffrand JP; LeFur G; Rostène W
    Eur J Pharmacol; 1994 Apr; 255(1-3):167-74. PubMed ID: 8026542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A machine-assisted flow synthesis of SR48692: a probe for the investigation of neurotensin receptor-1.
    Battilocchio C; Deadman BJ; Nikbin N; Kitching MO; Baxendale IR; Ley SV
    Chemistry; 2013 Jun; 19(24):7917-30. PubMed ID: 23592596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
    Miller LA; Cochrane DE; Feldberg RS; Carraway RE
    Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro.
    Mercuri NB; Calabresi P; Bernardi G
    Br J Pharmacol; 1989 Sep; 98(1):127-34. PubMed ID: 2804542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
    Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
    J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actions of cocaine on rat dopaminergic neurones in vitro.
    Lacey MG; Mercuri NB; North RA
    Br J Pharmacol; 1990 Apr; 99(4):731-5. PubMed ID: 2361170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Townsend CM
    Surg Oncol; 1996; 5(5-6):245-51. PubMed ID: 9129137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons.
    St-Gelais F; Legault M; Bourque MJ; Rompré PP; Trudeau LE
    J Neurosci; 2004 Mar; 24(10):2566-74. PubMed ID: 15014132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nomifensine but not amantadine increases dopamine-induced responses on rat substantia nigra zona compacta neurons.
    Mercuri NB; Stratta F; Calabresi P; Bernardi G
    Neurosci Lett; 1991 Oct; 131(2):145-8. PubMed ID: 1662338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study.
    Martorana A; Martella G; D'Angelo V; Fusco FR; Spadoni F; Bernardi G; Stefani A
    Synapse; 2006 Oct; 60(5):371-83. PubMed ID: 16838364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.
    Dubuc I; Costentin J; Terranova JP; Barnouin MC; Soubrié P; Le Fur G; Rostène W; Kitabgi P
    Br J Pharmacol; 1994 Jun; 112(2):352-4. PubMed ID: 8075852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor.
    Botto JM; Guillemare E; Vincent JP; Mazella J
    Neurosci Lett; 1997 Feb; 223(3):193-6. PubMed ID: 9080465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.